Polyarteritis Nodosa / GPA - Orthopaedic Relevance
- The systemic VASCULITIDES are rare, multi-organ INFLAMMATORY disorders of BLOOD VESSELS, classified by the SIZE of the vessel involved (Chapel Hill): LARGE-vessel (giant-cell/temporal arteritis, Takayasu), MEDIUM-vessel (POLYARTERITIS NODOSA, Kawasaki), and SMALL-vessel (the ANCA-associated vasculitides - GPA, microscopic polyangiitis, EGPA - and immune-complex types) - according to PubMed, examples such as Takayasu (large), polyarteritis nodosa (medium) and lupus/drug-induced (small) each show distinct imaging features.
- POLYARTERITIS NODOSA (PAN) is a necrotising MEDIUM-vessel arteritis that forms ANEURYSMS (a beaded/'rosary' appearance on angiography) and causes skin lesions (nodules, livedo reticularis, ulcers), MONONEURITIS MULTIPLEX, renal, gastrointestinal and limb ISCHAEMIA; it characteristically SPARES the lungs and is usually ANCA-NEGATIVE (and may be hepatitis-B-associated).
- GRANULOMATOSIS WITH POLYANGIITIS (GPA, formerly Wegener's) is a small-vessel ANCA-associated vasculitis with the classic triad of upper-airway/ENT, lung and kidney involvement (c-ANCA/anti-PR3), alongside microscopic polyangiitis (p-ANCA/anti-MPO) and eosinophilic GPA (asthma, eosinophilia) - these are the small-vessel diseases to recognise.
- The MUSCULOSKELETAL manifestations are common but usually non-specific: ARTHRALGIA and MYALGIA and a usually NON-EROSIVE inflammatory ARTHRITIS, plus constitutional symptoms (fever, weight loss, malaise) and raised inflammatory markers - so a vasculitis can present with limb/joint symptoms before its organ-specific features.
- The ORTHOPAEDICALLY DANGEROUS manifestations are vascular and neural: LIMB and DIGITAL ISCHAEMIA progressing to GANGRENE, and MONONEURITIS MULTIPLEX (a vasculitic neuropathy causing, for example, foot drop or wrist drop) - these can be mistaken for primary peripheral vascular disease, an entrapment neuropathy or a compartment/orthopaedic problem, and the error of treating the limb without recognising the vasculitis leads to ongoing tissue loss.
- The KEY PRINCIPLE is that recognition leads to URGENT IMMUNOSUPPRESSION, not surgery alone: systemic vasculitis is treated with CORTICOSTEROIDS plus CYCLOPHOSPHAMIDE or RITUXIMAB for induction (with maintenance immunosuppression), addressing any trigger (e.g. hepatitis B in PAN); surgical management of ischaemic tissue/gangrene or nerve palsy must occur ALONGSIDE controlling the underlying disease, because an amputation or decompression without immunosuppression will be undermined by ongoing vasculitis.
- “Classify vasculitis by VESSEL SIZE: large (GCA/Takayasu), medium (PAN, Kawasaki), small/ANCA (GPA c-ANCA/PR3, MPA p-ANCA/MPO, EGPA). PAN = aneurysms, spares lungs, usually ANCA-negative (HBV link).
- “MSK = arthralgia/myalgia + usually NON-EROSIVE arthritis + constitutional symptoms. DANGER = digital/limb ischaemia/gangrene and MONONEURITIS MULTIPLEX (foot/wrist drop) - can mimic primary orthopaedic/vascular disease.
- “Recognition -> URGENT immunosuppression (steroids + cyclophosphamide/rituximab). Surgery on ischaemic tissue/nerve must go WITH treating the vasculitis - surgery alone fails.
Digital/limb gangrene or a foot/wrist drop (mononeuritis multiplex) can be misread as peripheral vascular disease, an entrapment neuropathy or a compartment/orthopaedic problem - while the underlying vasculitis goes untreated.
Recognise the systemic picture (constitutional symptoms, multi-organ involvement, raised inflammatory markers, ANCA) and start urgent immunosuppression - surgery on the ischaemic limb must go with disease control.
Classification & Key Diseases
The vasculitides are classified by vessel size: large (giant-cell/temporal arteritis, Takayasu), medium (polyarteritis nodosa, Kawasaki) and small (the ANCA-associated vasculitides - GPA, microscopic polyangiitis, EGPA). PAN is a necrotising medium-vessel arteritis with aneurysms, causing skin, nerve (mononeuritis multiplex), renal, GI and limb ischaemia, sparing the lungs and usually ANCA-negative (HBV-associated). GPA (c-ANCA/PR3) gives the ENT-lung-kidney triad, with microscopic polyangiitis (p-ANCA/MPO) and eosinophilic GPA (asthma/eosinophilia) completing the small-vessel group.
| Group | Examples | MSK / limb relevance |
|---|---|---|
| Large | Giant-cell (temporal) arteritis, Takayasu | Polymyalgia rheumatica overlap; limb claudication (Takayasu) |
| Medium | Polyarteritis nodosa, Kawasaki | Myalgia, mononeuritis multiplex, digital/limb ischaemia & gangrene |
| Small (ANCA) | GPA, microscopic polyangiitis, EGPA | Arthralgia/arthritis, mononeuritis multiplex, digital ischaemia |
Orthopaedic Manifestations & Management
- MSK manifestations: arthralgia/myalgia, a usually non-erosive arthritis, constitutional symptoms - often non-specific and may precede organ-specific features.
- Limb-threatening: digital/peripheral ischaemia and gangrene, and mononeuritis multiplex (vasculitic neuropathy - foot/wrist drop) - do not mistake for primary vascular/entrapment/orthopaedic disease.
- Recognition is the key step: constitutional symptoms + multi-organ involvement + raised inflammatory markers
- ANCA/serology + biopsy/angiography.
- Urgent immunosuppression: corticosteroids + cyclophosphamide or rituximab for induction, then maintenance; treat any trigger (HBV in PAN).
- Surgery alongside disease control: debride/amputate gangrenous tissue and manage nerve palsies, but only with the vasculitis controlled - surgery alone, with the disease untreated, fails.
The orthopaedic pitfall with the vasculitides is to treat the limb manifestation as a primary orthopaedic or vascular problem while the underlying systemic vasculitis goes unrecognised and untreated. Digital and peripheral ischaemia progressing to gangrene can be mistaken for atherosclerotic peripheral vascular disease, and a vasculitic mononeuritis multiplex causing a foot drop or wrist drop can be mistaken for an entrapment neuropathy or compartment syndrome - but an amputation, revascularisation or nerve decompression performed without controlling the vasculitis will be undermined by ongoing inflammatory vessel disease, with further tissue loss. The safe approach is to recognise the systemic picture - constitutional symptoms, multi-organ involvement, raised inflammatory markers and ANCA/serology - and to start urgent immunosuppression (corticosteroids plus cyclophosphamide or rituximab, treating any trigger such as hepatitis B in PAN), with any necessary surgery for gangrenous tissue or nerve palsy performed alongside, not instead of, disease control.
Evidence & Key Studies
Imaging classification of vasculitis by vessel size (Takayasu, PAN, small-vessel)
- Systemic vasculitides are rare, multi-organ inflammatory disorders of blood vessels, classified by the size of the affected vessel.
- Examples include Takayasu arteritis (large vessels), polyarteritis nodosa (medium vessels), and lupus-associated or drug-induced vasculitis (small vessels), each with distinct imaging features (e.g. CT angiography).
- Early recognition of the imaging findings is crucial for accurate diagnosis, appropriate treatment and assessing the need for surgical intervention.
Polyarteritis-nodosa-like vasculitis in DADA2 - a medium-vessel vasculitis example
- Deficiency of adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disease whose small- and medium-sized vessel involvement can produce features resembling polyarteritis nodosa.
- Medium-vessel vasculitis can present with systemic inflammation (fever, weight loss, raised inflammatory markers) and serious organ involvement, and was treated successfully with immunosuppression (corticosteroids and a TNF inhibitor).
- Illustrates that medium-vessel vasculitis is managed with immunosuppression directed at the underlying inflammatory process.
According to PubMed, the classification of the vasculitides by vessel size (large/Takayasu, medium/polyarteritis nodosa, small) and the importance of recognition for diagnosis and deciding on surgical intervention come from the cited Rahmatullah imaging review; the medium-vessel (PAN-like) phenotype with systemic inflammation responding to immunosuppression from the cited Al-Ghoul (DADA2) report. The MSK manifestations (arthralgia/myalgia, non-erosive arthritis), the limb-threatening ischaemia/gangrene and mononeuritis multiplex, the ANCA associations of GPA/MPA/ EGPA, and the principle of urgent immunosuppression (steroids + cyclophosphamide/rituximab) with surgery alongside disease control are standard, well-established teaching. (See also our Raynaud's Phenomenon, Thromboangiitis Obliterans (Buerger's) and Peripheral Nerve Injury topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A patient presents with a foot drop and digital ischaemia, plus fever, weight loss and raised inflammatory markers. Why should you think beyond a simple nerve or vascular problem?”
Mnemonics & Memory Aids
VESSEL
Hook:VESSEL: Vessel size, Examples (GCA/PAN/GPA), Systemic symptoms, ischaemia/mononeuritis, Easily mistaken, Look + immunosuppress.
Classification (vessel size)
- Large: giant-cell (temporal) arteritis, Takayasu
- Medium: polyarteritis nodosa (aneurysms, spares lungs, usually ANCA-negative, HBV link), Kawasaki
- Small/ANCA: GPA (c-ANCA/PR3), microscopic polyangiitis (p-ANCA/MPO), EGPA (asthma/eosinophilia)
MSK manifestations
- Arthralgia/myalgia + usually non-erosive arthritis
- Constitutional symptoms (fever, weight loss) + raised inflammatory markers
- May precede organ-specific features
Limb-threatening / the trap
- Digital/peripheral ischaemia -> gangrene (mimics PVD)
- Mononeuritis multiplex -> foot/wrist drop (mimics entrapment neuropathy)
- Don't treat the limb as primary orthopaedic/vascular disease
Management
- Recognise systemic picture; ANCA/serology, biopsy/angiography
- Urgent immunosuppression: steroids + cyclophosphamide or rituximab (treat HBV in PAN)
- Surgery for gangrene/nerve palsy alongside disease control - not alone